[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BRPI0409293A - medicamento para a prevenção ou tratamento de doenças angiogênicas intraoculares - Google Patents

medicamento para a prevenção ou tratamento de doenças angiogênicas intraoculares

Info

Publication number
BRPI0409293A
BRPI0409293A BRPI0409293-7A BRPI0409293A BRPI0409293A BR PI0409293 A BRPI0409293 A BR PI0409293A BR PI0409293 A BRPI0409293 A BR PI0409293A BR PI0409293 A BRPI0409293 A BR PI0409293A
Authority
BR
Brazil
Prior art keywords
prevention
treatment
medicine
angiogenic diseases
methyl
Prior art date
Application number
BRPI0409293-7A
Other languages
English (en)
Inventor
Tomihisa Yokoyama
Tatsuya Inoue
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of BRPI0409293A publication Critical patent/BRPI0409293A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"MEDICAMENTO PARA A PREVENçãO OU O TRATAMENTO DE DOENçAS ANGIOGêNICAS INTRAOCULARES". Uma droga para prevenir ou tratar doenças angiogênicas de olho tais como retinopatia proliferativa, obstrução de veia retinal, obstrução de artéria retinal ou degeneração macular relacionada com a idade que contém como o ingrediente ativo um antagonista de receptor de angiotensina II tal como ácido 4-(1-hidróxi-1-metil-etil)-2-propil-1-¢2<39>-(1H-tetrazol-5-il)-bifenil4-il-m etil!-imidazol-5-carboxílico.
BRPI0409293-7A 2003-04-15 2004-02-18 medicamento para a prevenção ou tratamento de doenças angiogênicas intraoculares BRPI0409293A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003109918 2003-04-15
PCT/JP2004/001818 WO2004091659A1 (ja) 2003-04-15 2004-02-18 眼内血管新生性疾患の予防又は治療のための医薬

Publications (1)

Publication Number Publication Date
BRPI0409293A true BRPI0409293A (pt) 2006-04-11

Family

ID=33295936

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409293-7A BRPI0409293A (pt) 2003-04-15 2004-02-18 medicamento para a prevenção ou tratamento de doenças angiogênicas intraoculares

Country Status (10)

Country Link
US (1) US20070203211A1 (pt)
EP (2) EP2517728B1 (pt)
JP (2) JP4489020B2 (pt)
KR (1) KR101087519B1 (pt)
CN (1) CN1798576B (pt)
BR (1) BRPI0409293A (pt)
CA (1) CA2522318C (pt)
ES (1) ES2535291T3 (pt)
TW (1) TWI349549B (pt)
WO (1) WO2004091659A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087900A1 (ja) * 2008-01-11 2009-07-16 Daiichi Sankyo Company, Limited 眼内血管透過性亢進を伴う疾患の予防または治療のための医薬
KR100893652B1 (ko) * 2008-11-10 2009-04-17 주식회사종근당 신규한 텔미사르탄 아연염 및 그의 제조방법
JP5860210B2 (ja) * 2010-12-07 2016-02-16 株式会社オフテクス アンジオテンシンｉｉ受容体拮抗薬であるテルミサルタン及びロサルタンの少なくとも１種を有効成分とする涙液分泌促進用組成物、及びそれを含有する涙液分泌促進用経口投与用製剤
JP6010441B2 (ja) * 2011-12-06 2016-10-19 株式会社ハイマート ノコギリヤシ果実のエタノール抽出物または赤色素を含有する血管新生抑制剤および赤色素の製造方法
US20190282792A1 (en) * 2016-07-20 2019-09-19 P&X Medical Nv Compounds for use in methods for treating glaucoma and retinal diseases
CN107157999A (zh) * 2017-05-27 2017-09-15 青岛海蓝医药有限公司 川芎嗪硝酮衍生物在预防和治疗糖尿病并发症疾病中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
IS1756B (is) 1991-02-21 2000-12-28 Sankyo Company Limited Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða
DE69329982T2 (de) * 1992-06-02 2001-09-27 Sankyo Co., Ltd. 4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung
MX9603259A (es) * 1994-02-08 1997-03-29 Novartis Ag Tratamiento de glaucoma normotensivo con antagonistas de angiotensina ii.
KR100211446B1 (ko) * 1994-03-16 1999-08-02 가와무라 요시부미 안압 저하제
JP4276768B2 (ja) 1999-04-28 2009-06-10 武田薬品工業株式会社 単純網膜症・前増殖網膜症の予防・治療・進展抑制剤
WO2000066161A1 (fr) * 1999-04-28 2000-11-09 Takeda Chemical Industries, Ltd. Preventifs / remedes / inhibiteurs de progression pour retinopathie simplex ou retinopathie preproliferante
PE20020617A1 (es) * 2000-08-22 2002-08-05 Novartis Ag Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
WO2002045748A1 (fr) * 2000-12-05 2002-06-13 Sankyo Company, Limited Compositions d'abaissement de la tension oculaire pour administration topique
JP4132798B2 (ja) * 2000-12-05 2008-08-13 第一三共株式会社 局所投与のための眼圧低下組成物
EP1369130A1 (en) * 2001-03-16 2003-12-10 Takeda Chemical Industries, Ltd. Process for producing sustained release preparation
US20040132731A1 (en) * 2002-06-26 2004-07-08 Fox David Nathan Abraham Novel combination
US20050038093A1 (en) * 2003-05-02 2005-02-17 Boehringer Ingelheim International Gmbh Treating diabetic retinopathy with angiotensin II receptor blockers

Also Published As

Publication number Publication date
ES2535291T3 (es) 2015-05-08
JPWO2004091659A1 (ja) 2006-07-06
EP2517728A1 (en) 2012-10-31
TW200503684A (en) 2005-02-01
EP2517728B1 (en) 2015-01-28
US20070203211A1 (en) 2007-08-30
JP4489020B2 (ja) 2010-06-23
CA2522318C (en) 2011-09-13
CA2522318A1 (en) 2004-10-28
EP1614428A1 (en) 2006-01-11
WO2004091659A1 (ja) 2004-10-28
JP2010143933A (ja) 2010-07-01
TWI349549B (en) 2011-10-01
CN1798576B (zh) 2012-09-26
KR101087519B1 (ko) 2011-11-28
KR20050120714A (ko) 2005-12-22
EP1614428A4 (en) 2010-01-06
CN1798576A (zh) 2006-07-05

Similar Documents

Publication Publication Date Title
WO2010068281A3 (en) Contact lens drug delivery device
BRPI0408690A (pt) composto, método para tratamento de uma doença, composição farmacêutica, e, uso de um composto
WO2006002366A3 (en) Biodegradable ocular devices, methods and systems
BRPI0520588B8 (pt) uso de composições farmacêuticas para o tratamento de doenças do ouvido interno
NO20061151L (no) Succinat- og malonatsalt av trans-4-((ir,3s)-6-klor-3-fenylindan-i-yl)-1,2,2-trimetylpiperazin og anvendelsen som et medikament
BR112012025581A2 (pt) implantes de reservatório de liberação sustentada para distribuição de fármaco intracameral
WO2003092584A3 (en) Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
BRPI0616574A2 (pt) derivado de sulfonamida tendo atividade antagonìstica de receptor de pgd2
WO2008027371A3 (en) Low profile bioactive agent delivery device
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
EP2156833A4 (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR POSTERIOR EYES DISEASE WITH SELF-SELECTIVE NON-ERGOT D2 RECEPTOR AGONIST AS AN ACTIVE SUBSTANCE
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
BR112021026397A2 (pt) Antagonista de ep2
AR004214A1 (es) Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
NO20092764L (no) Isosorbid mononitrat derivater for behandling av okular hypertensjon
BRPI0409293A (pt) medicamento para a prevenção ou tratamento de doenças angiogênicas intraoculares
TW200616644A (en) Medicine for prevention or treatment of diabetes
BR0314419A (pt) Compostos de 5-croman-5-il-etilamina substituìdos, seu uso e composição farmacêutica incluindo-o
DK2692345T3 (en) Pharmaceutical composition for the prevention or treatment of macular degeneration
BR0307013A (pt) Usos farmacêuticos
EP1482922A4 (en) AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERS
BR0104586A (pt) Método para tratamento de neurodegeneração
WO2008142198A3 (en) A method for inhibiting or stimulating angiogenesis in an individual
AR036194A1 (es) Uso de compuestos para la fabricacion de un medicamento que promueven la regeneracion de las neuronas o de las excrecencias neuriticas para el tratamiento de xeroftalmia y para la diminucion de la sensibilidad de la cornea despues de lasik u otras cirugias cuando los nervios corneales estan lesionad
MX2020007627A (es) Uso de la carrimicina o de sus ingredientes activos.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]